Helping mothers and babies, from conception to birth
At Ferring, we are committed to helping people become parents and to keeping mothers and babies healthy, from conception to birth. Over one third of our research and development investment goes towards finding innovative treatments in reproductive medicine and maternal health. We are also passionate about making a difference to people’s health and quality of life through our work in urology, gastroenterology, endocrinology and orthopaedics.
Twitter Feed
Twitter Feed
What we do
Ferring Pharmaceuticals is devoted to identifying, developing and marketing innovative products in reproductive and maternal health, urology, gastroenterology, endocrinology and orthopaedics.
Read MoreLatest news
-
Thursday, 05 December 2019 FerGene announces pivotal Phase 3 study of nadofaragene firadenovec met its primary endpoint with more than half of patients with high-grade non-muscle invasive bladder cancer (CIS ± Ta/T1) achieving a complete response at three monthsRead more >
-
Monday, 25 November 2019 Ferring and Blackstone Life Sciences invest over $570 million USD in novel gene therapy for bladder cancer patientsRead more >
-
Tuesday, 09 July 2019 Heat-stable carbetocin has been added to the WHO Essential Medicines List for the prevention of excessive bleeding after childbirth Read more >
